Search Results - "Weinberg, Rona S."

Refine Results
  1. 1
  2. 2
  3. 3

    Role of epigenetic modifications in normal globin gene regulation and butyrate-mediated induction of fetal hemoglobin by Fathallah, Hassana, Weinberg, Rona S., Galperin, Yelena, Sutton, Millicent, Atweh, George F.

    Published in Blood (01-11-2007)
    “…Butyrate is a prototype of histone deacetylase inhibitors that is believed to reactivate silent genes by inducing epigenetic modifications. Although butyrate…”
    Get full text
    Journal Article
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8

    Validation of simple prediction algorithms to consistently achieve CD3+ and postselection CD34+ targets with leukapheresis by Yoon, Edward J., Zhang, Jiahao, Weinberg, Rona S., Brochstein, Joel A., Nandi, Vijay, Sachais, Bruce S., Shi, Patricia A.

    Published in Transfusion (Philadelphia, Pa.) (01-01-2020)
    “…BACKGROUND Cellular therapies using engineered T cells, haploidentical transplants, and autologous gene therapy are increasing. Specified CD3+ or high CD34+…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Butyrate increases the efficiency of translation of γ-globin mRNA by Weinberg, Rona S., Ji, Xinjun, Sutton, Millicent, Perrine, Susan, Galperin, Yelena, Li, Qiliang, Liebhaber, Stephen A., Stamatoyannopoulos, George, Atweh, George F.

    Published in Blood (15-02-2005)
    “…Fetal hemoglobin (Hb F) levels increase in most patients with sickle cell disease following intermittent butyrate therapy. Although the full effects of…”
    Get full text
    Journal Article
  11. 11
  12. 12
  13. 13

    Hemoglobinopathies by Atweh, George F, DeSimone, Joseph, Saunthararajah, Yogen, Fathallah, Hassana, Weinberg, Rona S, Nagel, Ronald L, Fabry, Mary E, Adams, Robert J

    Published in Hematology (2003)
    “…The outlook for patients with sickle cell disease has improved steadily during the last two decades. In spite of these improvements, curative therapies are…”
    Get full text
    Journal Article
  14. 14

    Second generation knockout sickle mice: the effect of HbF by Fabry, Mary E., Suzuka, Sandra M., Weinberg, Rona S., Lawrence, Christine, Factor, Stephen M., Gilman, John G., Costantini, Frank, Nagel, Ronald L.

    Published in Blood (15-01-2001)
    “…Sickle transgenic mice expressing exclusively human globins are desirable for studying pathophysiology and testing gene therapy strategies, but they must have…”
    Get full text
    Journal Article
  15. 15
  16. 16
  17. 17
  18. 18

    Syngeneic stem cell transplant for spent‐phase polycythaemia vera: eradication of myelofibrosis and restoration of normal haematopoiesis by Richard, Shambavi, Isola, Luis, Scigliano, Eileen, Singh, Harvinder, Najfeld, Vesna, Gilbert, Harriet, Weinberg, Rona S., Fruchtman, Steven

    Published in British journal of haematology (01-04-2002)
    “…We report a patient with spent‐phase polycythaemia vera (S‐PV) and massive splenomegaly who failed to engraft after a syngeneic granulocyte colony‐stimulating…”
    Get full text
    Journal Article
  19. 19

    In Vivo Silencing of the Human γ-Globin Gene in Murine Erythroid Cells Following Retroviral Transduction by Lung, Hui-yu, Meeus, Ilse S, Weinberg, Rona S, Atweh, George F

    Published in Blood cells, molecules, & diseases (01-12-2000)
    “…ABSTRACT Increased expression of fetal hemoglobin can ameliorate the clinical severity of sickle cell disease. Whereas temporary induction of fetal hemoglobin…”
    Get full text
    Journal Article
  20. 20

    Malignant cells can be sensitized to undergo growth inhibition and apoptosis by arsenic trioxide through modulation of the glutathione redox system by JIE DAI, WEINBERG, R. S, WAXMAN, S, YONGKUI JING

    Published in Blood (1999)
    “…Arsenic trioxide (As2O3) induces clinical remission in acute promyelocytic leukemia (APL) with minimal toxicity and apoptosis in APL-derived NB4 cells at low…”
    Get full text
    Journal Article